Related Experiment Video
Updated: May 5, 2026
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
Lobarstin enhances chemosensitivity in human glioblastoma T98G cells
Sojin Kim1, Sungsin Jo, Hongki Lee
1Department of Pathology, College of Medicine, Hanyang University, 222 Wangsimni-ro, Seondong-gu, Seoul, 133-791, Republic of Korea. hc2n@hanyang.ac.kr.
Background/Aim:
Lobarstin is a metabolite occurring from the Antarctic lichen Stereocaulon alpnum. Human glioblastoma is highly resistant to chemotherapy with temozolomide. Lobarstin was examined for its effect on glioblastoma.
Materials And Methods:
Temozolomide-resistant T98G cells were subjected to toxicity test with temozolomide and/or lobarstin. DNA damage and recovery was assessed by the alkaline comet assay and expression of DNA repair genes was examined by RT-PCR and western blot analysis.
Results:
Lobarstin alone at 40 μM was toxic against T98G, but had no effect in primary human fibroblasts. Co-treatment of lobarstin with temozolomide yielded enhanced toxicity. Temozolomide-alone or with lobarstin co-treatment gave similar extent of DNA damage. However, the recovery was reduced in co-treated cells. Expression of DNA repair genes, O(6)-methylguanine-DNA methyltransferase, poly(ADP-ribose) polymerase 1 and ligase 3 were reduced in lobarstin-treated cells.
Conclusion:
Enhanced sensitivity to temozolomide by lobarstin co-treatment may be attributed to reduced DNA repair.
